Bioventus Cash Flow Statement (2020-2026) | BVS

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Apr2021 Jul2021 Oct2021 Dec2021 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-10.78M-2.27M-0.03M-0.40M-0.28M-44.66M-23.40M-74.43M-3.32M9.27M4.01M17.32M3.95M
Share-based Compensation (Quarter)
5.85M5.94M6.11M4.89M4.62M4.65M3.43M1.85M-2.73M1.83M1.77M2.99M5.78M2.49M2.02M2.41M3.64M3.18M3.44M3.26M
Deferred Taxes (Quarter)
-1.06M-0.72M-8.05M-17.02M-10.68M-7.19M-11.77M-2.66M-0.88M1.16M0.08M-8.18M-0.51M3.21M0.04M0.04M0.14M-1.13M0.14M
Cash from Discontinued Operations (Quarter)
-0.86M-1.27M-2.17M
Gains from Investment Securities (Quarter)
0.64M0.65M-1.29M0.27M0.27M0.28M0.28M0.29M0.24M-0.10M0.29M0.29M0.30M0.48M0.34M1.04M
Asset Writedowns and Impairment (Quarter)
-0.55M0.22M0.62M124.70M10.29M1.08M-0.98M31.87M2.03M36.97M0.65M0.19M-0.84M0.23M
Change in Working Capital (Quarter)
3.85M0.71M1.13M
Cash from Operations (Quarter)
17.33M10.59M13.12M-21.02M2.94M0.16M6.51M2.49M10.79M-6.15M10.37M-6.00M15.16M10.32M19.32M-19.33M25.94M30.10M37.97M8.93M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
189.20M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
7.48M8.52M11.69M12.48M12.38M13.59M16.94M16.47M14.60M13.83M12.46M11.79M13.09M12.28M12.40M11.87M12.05M11.40M11.69M11.21M
Change in Working Capital
Change in Receivables (Quarter)
11.98M3.78M6.90M-4.42M25.57M-8.32M4.83M-13.16M1.83M-7.92M9.19M1.96M19.98M-17.06M5.79M-9.00M13.63M-1.82M-1.89M-7.32M
Change in Inventory (Quarter)
-6.96M2.42M-1.69M-0.33M2.94M6.01M10.00M5.29M7.78M1.05M-8.13M4.07M4.29M2.52M5.56M1.88M2.81M-0.29M-12.97M2.65M
Change in Accured Expenses (Quarter)
16.99M4.33M10.96M-7.92M25.66M-35.16M14.31M2.33M12.43M-25.83M5.79M-7.33M29.88M-21.33M16.62M-39.10M16.42M7.31M-4.44M-15.37M
Other Working Capital Changes (Quarter)
12.62M0.71M-13.13M1.53M-4.67M3.30M-9.82M2.13M-0.99M0.26M0.57M0.58M0.89M-6.33M7.66M-0.78M1.54M-3.29M3.68M0.28M
Investing Activities
Capital Expenditures (Quarter)
1.27M-2.03M12.91M2.96M2.03M1.65M-5.16M3.56M1.40M-3.65M6.06M0.29M-0.09M-0.09M0.89M0.14M1.37M-1.29M0.02M0.53M
Acquisitions (Quarter)
-0.00M-45.79M262.87M0.24M-0.01M104.61M
Divestments (Quarter)
-104.84M-11.51M46.40M-46.40M
Cash from Investing Activities (Quarter)
-2.65M-13.19M-221.28M-4.67M-52.02M-56.33M-3.40M-3.56M21.99M-2.04M10.91M-1.00M-0.08M-0.06M24.10M-0.83M-1.37M-0.47M-0.58M-0.57M
Financing Activities
Other financing activities (Quarter)
-0.01M-0.02M0.03M-0.01M-0.01M0.02M-0.01M-0.04M-0.13M-0.17M-0.17M-0.18M-0.19M-0.19M-0.19M-0.20M-0.21M-0.21M1.32M-0.22M
Cash from Financing Activities (Quarter)
-6.12M-4.35M176.31M9.21M7.66M50.65M-5.44M27.38M-62.25M8.23M-0.01M-4.24M-7.84M0.36M-42.85M0.95M-14.66M-19.98M-28.45M-23.14M
Additional items
Exchange Rate Effect (Quarter)
0.05M-0.21M0.15M-0.07M-0.22M-0.24M1.05M0.46M0.24M-0.44M0.37M-0.54M-0.42M0.47M-2.06M0.43M0.20M-0.39M0.13M-0.61M
Change in Cash (Quarter)
8.61M-7.15M-31.70M-16.56M-41.65M-6.62M-2.54M15.27M-17.71M-2.56M10.14M-11.79M6.82M11.08M-1.49M-18.78M10.11M9.25M9.07M-15.39M
Free Cash Flow (Quarter)
16.06M12.62M0.21M-23.98M0.91M-1.49M11.68M-1.07M9.40M-2.49M4.32M-6.30M15.25M10.41M18.43M-19.47M24.57M31.39M37.95M8.40M
Net Cash Flow (Quarter)
8.56M-6.95M-31.85M-16.49M-41.43M-5.52M-2.33M26.31M-29.46M0.05M21.27M-11.25M7.24M10.61M0.57M-19.21M9.91M9.65M8.94M-14.78M